Amend-1 Questions and Responses.docx
DOCX document 16 KB Posted
- Solicitation number
- RFP-23-PHX-30
About this file
This document is an amendment containing questions and responses regarding solicitation number RFP-23-PHX-30 from the Department of Health and Human Services Indian Health Service. The amendment revises the statement of work to remove the requirement for a biopsy system, as the agency has since learned the Revolve biopsy system purchased in 2018 is compatible with upright mammography units. The sole remaining requirement is for an upright biopsy chair. The amendment also extends the offer due date to July 31, 2023 and does not change any other timeframe requirements. The agency may or may not continue use of the prone biopsy table for one or two more years alongside the new upright biopsy chair.
View the file
Other files
Show all 21
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Amendment 1, Question and Responses
1. The current stereo suite utilizes a prone biopsy table, does the department intend to continue use of prone biopsy alongside upright biopsy or change to all upright biopsy moving forward? Our goal is to move toward an upright biopsy chair. We may or may not continue use of the biopsy table or continue for one or two more years.
1. Department purchased comparable biopsy system (Mammotome Revolve) in 2018. Are you aware that the Revolve biopsy system is compatible with all upright mammography units including the Hologic 3Dimensions? We were not aware and have since revised to SOW to remove the biopsy system from the requirement. We will still require the upright biopsy chair.
1. Revised SOW, see Attachment Amend-1 Attachment A – SOW Mammography
1. Extend Offer Due Date to July 31, 2023 and no changes to time.
File details come from the government source that posted it. Updated .